Literature DB >> 624027

Antibody to hepatitis B core antigen in chronic active hepatitis.

P Bories, P Coursaget, A Goudeau, C Degott, P Maupas, J P Benhamou.   

Abstract

Antibody to hepatitis B core antigen (anti-HBc), which has been assumed to be a more sensitive indicator of hepatitis B virus replication than hepatitis B surface antigen (HBsAg), was detected in the sera of 26 of our 65 patients with HBsAg-negative chronic active hepatitis. Thus despite the absence of HBsAg the liver disease could be the consequence of chronic infection with hepatitis B virus in these patients. They differed, however, from a group of 35 patients with HBsAg-positive hepatitis in being older on average and having less active liver lesions. The two groups could represent either two stages of chronic infection with hepatitis B virus or two types of response to it.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624027      PMCID: PMC1602952          DOI: 10.1136/bmj.1.6110.396

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Automated complement fixation test for the detection of antibodies against the core of hepatitis B virus (HBc).

Authors:  P Coursaget; P Maupas; A Goudeau; I Millman
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

2.  Viral hepatitis and cirrhosis.

Authors:  S Sherlock
Journal:  Clin Gastroenterol       Date:  1975-05

3.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

4.  Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.

Authors:  P Maupas; B Werner; B Larouzé; I Millman; W T London; A O'Connell; B S Blumberg
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

5.  Letter: Core antigen in chronic active hepatitis.

Authors:  J P Benhamou; P Maupas; B Pillegand
Journal:  Lancet       Date:  1976-04-10       Impact factor: 79.321

6.  Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.

Authors:  Y Kubo; K Okuda; M Hashimoto; Y Nagasaki; H Ebata
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

7.  Anti-HBc titer in relation to the etiological role of hepatitis B virus in primary hepatocellular carcinoma.

Authors:  S Furuta; A Nagata; K Kiyosawa; Y Akahane; Y Koike; T Sahara; M Oda; M Mayumi; F Tsuda
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1977-02

8.  Antibody to hepatitis B core antigen in chronic hepatitis and primary biliary cirrhosis: evaluation by a new autologous solid phase radioimmunoassay.

Authors:  G F Grady; M M Kaplan; G N Vyas
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

9.  [The rate constant K37 in complement fixation tests: kinetic studies on the influenza virus-immune complex model (author's transl)].

Authors:  P Coursaget; P Maupas; R Vargues
Journal:  Ann Microbiol (Paris)       Date:  1976 Aug-Sep

10.  Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

  10 in total
  5 in total

1.  Importance of showing HBsAg and HBcAg positivity in the liver for better aetiological definition of chronic liver disease.

Authors:  L Cuccurullo; M Rambaldi; G Iaquinto; F Ferraraccio; L Ambrosone; N Giardullo; A De Vita
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

2.  Evidence for hepatitis B and other virus infection in HBsAg-negative chronic active hepatitis.

Authors:  E Villa; P Jenkins; B Portmann; A L Eddleston; R Williams
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

3.  Hepatitis B core antigen in hepatocytes of patients with chronic active hepatitis.

Authors:  C Brechot; C Trepo; D Ninova-Bradistilova; A Goudeau; C Degott; P Maupas; F Potet; J P Benhamou
Journal:  Dig Dis Sci       Date:  1980-08       Impact factor: 3.199

4.  HBsAg clearance in chronic active hepatitis B. A possible cause of cryptogenic cirrhosis.

Authors:  T R Morgan; A G Redeker; S Yamada; M Ashcavai
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

5.  Incidence and significance of hepatitis B and A virus serologic markers in Greek cirrhotic patients.

Authors:  G Theodoropoulos; G Hadzis
Journal:  Gastroenterol Jpn       Date:  1985-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.